This animal study shows GHRP-6 (similar to Annular’s Growth-1295) significantly reduced lung injury and prevented progression to pulmonary fibrosis in mice. The peptide reduced inflammation, improved lung function, and preserved tissue integrity in both acute and chronic scenarios. This is the first study demonstrating lung protective effects for this class of peptides, potentially expanding therapeutic applications beyond traditional growth hormone benefits.
For your business
New research shows Growth-1295’s peptide class may offer unexpected lung protection benefits, potentially supporting respiratory health in addition to its established metabolic effects.